跳至主要内容
临床试验/NCT03310671
NCT03310671Unknown不适用

Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins

Instituto Aragones de Ciencias de la Salud1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2017年7月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
900
试验地点
1
主要终点
Differences in age-adjusted prevalence of EA assessed by transthoracic echocardiography between cases and controls

研究概览

简要总结

Aortic stenosis (AE) is a disease that has been increasing steadily in recent years in most countries, including Spain.Risk factors for the development of AE include age, hypercholesterolemia, diabetes mellitus and arterial hypertension, the classic risk factors for the development of atherosclerosis. However, lipid-lowering therapy with statins and ezetimibe has not been shown to reduce the risk of long-term progression of AE by unknown mechanisms. All this suggests that subjects with HFhe have a high risk of developing AD, which has not been shown by the high coronary mortality in this population that precedes aortic calcification

详细描述

The study includes a single clinical visit with collection of clinical data, blood extraction and the performance of a transthoracic echocardiogram. This visit may be made on different days, but always within 30 days of signing the informed consent.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 65 years at the time of cardiac ultrasound
  • Genetically diagnosed HFH or in a first-degree relative
  • History of hypercholesterolemia with LDLc levels> 220 mg / dL without lipid-lowering treatment
  • Genetically Similar
  • Siblings of the normoccholesterolemic case, defined by LDLc <190 mg / dl without lipid-lowering treatment.
  • In the absence of available siblings, first cousins may be included.
  • In the presence of several siblings available, the same sex will be included,
  • Environmentally similar
  • Stable partner of the case with cohabitation> 25 years * Each case will have at least one control.

排除标准

  • Personal history of cardiac rheumatic disease

结局指标

主要结局

Differences in age-adjusted prevalence of EA assessed by transthoracic echocardiography between cases and controls

时间窗: 1 YEAR

次要结局

  • Difference in aortic surface between cases and controls(1 YEAR)
  • Difference in the mean transvalvular gradient between cases and controls(1 YEAR)
  • Differences in age-adjusted prevalence of AD assessed by transthoracic echocardiography between cases and controls(1 YEAR)
  • Difference between maximum aortic jet velocity between cases and controls(1 YEAR)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Fernando Civeira

Instituto Aragonés de Ciencias de la Salud

Instituto Aragones de Ciencias de la Salud

研究点 (1)

Loading locations...

相似试验